{
  "content": "Sr HD, Nandkeolyar S, Lan H, et al. Amiodarone: a Comprehensive Guide for Clinicians. Am J Cardiovasc Drugs . 2020;20(6):549–558. doi:10.1161/CIRCULATIONAHA.109.875252 \n\nWells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med . 1994;121(9):676–683. doi:10.7326/ 0003-4819-121-9-199411010-00009 \n\nGrymonprez M, Carnoy L, Capiau A, et al. Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. Eur Heart J Cardiovasc Pharmacother ;2023. pvad070. doi:10.1093/ehjcvp/pvad070",
  "source": "https://pdfs.semanticscholar.org/8144/63bafca99ba37325c5ff5b8beec010b33efd.pdf?skipShowableCheck=true",
  "chunk_id": "6a9a9ed0-554a-443f-a2b0-73b2123da83c",
  "similarity_score": 0.328183650970459,
  "query": "amiodarone pharmacokinetics drug interactions CYP450 beta-blockers metabolism clearance atrial fibrillation dosing",
  "rank": 6,
  "title": "Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation",
  "authors": "Yihan Li, Tong Hu, Mingjie Lin, Qinhong Wang, Wenqiang Han, Jingquan Zhong",
  "year": "2023",
  "journal": "Clinical Pharmacology: Advances and Applications",
  "reference": "Li, Y., Hu, T., Lin, M., Wang, Q., Han, W., & Zhong, J. (2023). Comparison of efficacy and safety between dronedarone and amiodarone used during the blind period in patients with atrial fibrillation after catheter ablation. Clinical Pharmacology: Advances and Applications, 15, 113-123.",
  "doi": "Not available",
  "chunk_index": 80,
  "total_chunks": 84,
  "retrieved_at": "2025-07-24T21:58:09.739057"
}